US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist
  • 29.660
  • +0.750+2.59%
Close Mar 10 16:00 ET
  • 29.660
  • 0.0000.00%
Post 20:01 ET
933.86MMarket Cap15.95P/E (TTM)

Collegium Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-25.39%204.98M
15.42%84.64M
-112.16%-9M
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
Net income from continuing operations
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
259.03%27.71M
292.60%48.16M
543.67%31.94M
4,415.10%20.63M
350.57%13.01M
-33.34%-17.43M
Operating gains losses
-51.80%11.33M
--0
--4.15M
----
----
--23.5M
--0
--0
--0
--23.5M
Depreciation and amortization
13.34%169.16M
59.35%56.51M
12.37%41.75M
-7.54%35.47M
-7.44%35.43M
7.43%149.26M
-17.73%35.46M
-2.33%37.15M
0.53%38.36M
94.94%38.28M
Deferred tax
-1,145.42%-26.81M
-2,904.73%-10.16M
-670.79%-8.73M
-452.36%-3.51M
-9,491.30%-4.41M
74.34%-2.15M
68.65%-338K
-154.03%-1.13M
81.14%-636K
99.24%-46K
Other non cash items
-19.56%6.72M
-11.23%1.72M
-20.25%1.66M
-26.52%1.58M
-19.43%1.76M
-1.97%8.36M
-14.87%1.94M
-12.61%2.08M
-22.91%2.15M
103.73%2.18M
Change In working capital
-352.99%-54.98M
899.67%16.81M
-824.44%-63.95M
-105.56%-2.22M
77.41%-5.62M
270.94%21.73M
-108.93%-2.1M
258.18%8.83M
1,580.69%39.87M
24.78%-24.86M
-Change in receivables
-222.82%-4.41M
-95.44%106K
98.68%-190K
-178.66%-9.16M
21.01%4.83M
116.50%3.59M
-81.06%2.33M
-783.73%-14.37M
137.38%11.65M
179.76%3.99M
-Change in inventory
-1.71%13.93M
37.87%2.47M
186.25%6.99M
-50.30%3.41M
-92.24%1.06M
-70.65%14.17M
-90.12%1.79M
-161.74%-8.1M
-58.81%6.87M
4,023.03%13.61M
-Change in prepaid assets
-1,077.76%-14.07M
-239.44%-1.95M
-124.23%-434K
-661.81%-11.51M
25.63%-177K
131.24%1.44M
124.93%1.4M
137.85%1.79M
-249.77%-1.51M
-135.16%-238K
-Change in payables and accrued expense
-2,093.71%-50.42M
312.38%16.18M
-338.29%-70.32M
-34.20%15.04M
73.17%-11.33M
107.31%2.53M
-494.69%-7.62M
236.92%29.51M
32.28%22.86M
-45.33%-42.22M
Cash from discontinued investing activities
Operating cash flow
-25.39%204.98M
15.42%84.64M
-112.16%-9M
-32.41%67.4M
123.83%61.94M
121.16%274.75M
10.57%73.34M
73.06%74.02M
146.53%99.72M
209.31%27.67M
Investing cash flow
Cash flow from continuing investing activities
-306.37%-287.76M
53.13%-11.76M
-6,413.95%-248.96M
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
Net PPE purchase and sale
-258.35%-1.65M
-247.56%-570K
-275.38%-244K
-382.14%-270K
-222.73%-568K
71.58%-461K
82.55%-164K
42.48%-65K
87.85%-56K
-62.96%-176K
Net business purchase and sale
---267.54M
--0
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
73.61%-18.57M
55.11%-11.19M
600.90%18.82M
79.27%-8.64M
---17.56M
---70.35M
---24.93M
---3.76M
---41.66M
--0
Cash from discontinued investing activities
Investing cash flow
-306.37%-287.76M
53.13%-11.76M
-6,413.95%-248.96M
78.65%-8.91M
-10,200.00%-18.13M
87.66%-70.81M
-2,569.89%-25.1M
-3,282.30%-3.82M
-8,949.24%-41.72M
99.97%-176K
Financing cash flow
Cash flow from continuing financing activities
56.77%-60.6M
39.14%-41.28M
256.19%149.03M
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
Net issuance payments of debt
111.41%7.52M
64.77%-16.15M
424.10%148.55M
-70.86%-79.05M
-163.64%-45.83M
-114.89%-65.92M
-83.33%-45.83M
-83.34%-45.83M
-85.07%-46.27M
-86.09%72.02M
Net common stock issuance
19.97%-60.03M
-0.10%-25.03M
--0
----
----
-433.31%-75M
-227.18%-25M
---50M
----
----
Proceeds from stock option exercised by employees
21.67%11.07M
-94.66%173K
4.55%620K
357.15%5.72M
13.54%4.56M
-25.08%9.1M
-52.79%3.24M
114.86%593K
-19.03%1.25M
15.96%4.02M
Net other financing activities
-129.28%-19.17M
-19.74%-279K
17.44%-142K
-2,570.45%-5.88M
-66.42%-12.87M
-106.75%-8.36M
-417.78%-233K
-62.26%-172K
56.95%-220K
-128.74%-7.74M
Cash from discontinued financing activities
Financing cash flow
56.77%-60.6M
39.14%-41.28M
256.19%149.03M
-152.47%-114.21M
-179.28%-54.15M
-132.10%-140.18M
-162.66%-67.83M
-205.30%-95.41M
-88.75%-45.24M
-86.81%68.3M
Net cash flow
Beginning cash position
36.18%239.99M
-74.96%65.01M
-38.92%173.94M
-15.58%229.66M
36.18%239.99M
-6.74%176.24M
89.93%259.58M
127.35%284.8M
149.01%272.03M
-6.74%176.24M
Current changes in cash
-324.88%-143.38M
261.37%31.61M
-331.99%-108.93M
-536.34%-55.72M
-110.79%-10.34M
600.54%63.76M
-149.50%-19.59M
-321.12%-25.22M
-20.31%12.77M
220.15%95.79M
End cash Position
-59.74%96.61M
-59.74%96.61M
-74.96%65.01M
-38.92%173.94M
-15.58%229.66M
36.18%239.99M
36.18%239.99M
89.93%259.58M
127.35%284.8M
149.01%272.03M
Free cash flow
-25.87%203.33M
14.90%84.07M
-112.50%-9.24M
-32.65%67.13M
123.20%61.37M
123.71%274.29M
11.91%73.17M
73.37%73.95M
149.23%99.67M
208.15%27.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -25.39%204.98M15.42%84.64M-112.16%-9M-32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M
Net income from continuing operations 43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M259.03%27.71M292.60%48.16M543.67%31.94M4,415.10%20.63M350.57%13.01M-33.34%-17.43M
Operating gains losses -51.80%11.33M--0--4.15M----------23.5M--0--0--0--23.5M
Depreciation and amortization 13.34%169.16M59.35%56.51M12.37%41.75M-7.54%35.47M-7.44%35.43M7.43%149.26M-17.73%35.46M-2.33%37.15M0.53%38.36M94.94%38.28M
Deferred tax -1,145.42%-26.81M-2,904.73%-10.16M-670.79%-8.73M-452.36%-3.51M-9,491.30%-4.41M74.34%-2.15M68.65%-338K-154.03%-1.13M81.14%-636K99.24%-46K
Other non cash items -19.56%6.72M-11.23%1.72M-20.25%1.66M-26.52%1.58M-19.43%1.76M-1.97%8.36M-14.87%1.94M-12.61%2.08M-22.91%2.15M103.73%2.18M
Change In working capital -352.99%-54.98M899.67%16.81M-824.44%-63.95M-105.56%-2.22M77.41%-5.62M270.94%21.73M-108.93%-2.1M258.18%8.83M1,580.69%39.87M24.78%-24.86M
-Change in receivables -222.82%-4.41M-95.44%106K98.68%-190K-178.66%-9.16M21.01%4.83M116.50%3.59M-81.06%2.33M-783.73%-14.37M137.38%11.65M179.76%3.99M
-Change in inventory -1.71%13.93M37.87%2.47M186.25%6.99M-50.30%3.41M-92.24%1.06M-70.65%14.17M-90.12%1.79M-161.74%-8.1M-58.81%6.87M4,023.03%13.61M
-Change in prepaid assets -1,077.76%-14.07M-239.44%-1.95M-124.23%-434K-661.81%-11.51M25.63%-177K131.24%1.44M124.93%1.4M137.85%1.79M-249.77%-1.51M-135.16%-238K
-Change in payables and accrued expense -2,093.71%-50.42M312.38%16.18M-338.29%-70.32M-34.20%15.04M73.17%-11.33M107.31%2.53M-494.69%-7.62M236.92%29.51M32.28%22.86M-45.33%-42.22M
Cash from discontinued investing activities
Operating cash flow -25.39%204.98M15.42%84.64M-112.16%-9M-32.41%67.4M123.83%61.94M121.16%274.75M10.57%73.34M73.06%74.02M146.53%99.72M209.31%27.67M
Investing cash flow
Cash flow from continuing investing activities -306.37%-287.76M53.13%-11.76M-6,413.95%-248.96M78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K
Net PPE purchase and sale -258.35%-1.65M-247.56%-570K-275.38%-244K-382.14%-270K-222.73%-568K71.58%-461K82.55%-164K42.48%-65K87.85%-56K-62.96%-176K
Net business purchase and sale ---267.54M--0--------------0--0------------
Net investment purchase and sale 73.61%-18.57M55.11%-11.19M600.90%18.82M79.27%-8.64M---17.56M---70.35M---24.93M---3.76M---41.66M--0
Cash from discontinued investing activities
Investing cash flow -306.37%-287.76M53.13%-11.76M-6,413.95%-248.96M78.65%-8.91M-10,200.00%-18.13M87.66%-70.81M-2,569.89%-25.1M-3,282.30%-3.82M-8,949.24%-41.72M99.97%-176K
Financing cash flow
Cash flow from continuing financing activities 56.77%-60.6M39.14%-41.28M256.19%149.03M-152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M
Net issuance payments of debt 111.41%7.52M64.77%-16.15M424.10%148.55M-70.86%-79.05M-163.64%-45.83M-114.89%-65.92M-83.33%-45.83M-83.34%-45.83M-85.07%-46.27M-86.09%72.02M
Net common stock issuance 19.97%-60.03M-0.10%-25.03M--0---------433.31%-75M-227.18%-25M---50M--------
Proceeds from stock option exercised by employees 21.67%11.07M-94.66%173K4.55%620K357.15%5.72M13.54%4.56M-25.08%9.1M-52.79%3.24M114.86%593K-19.03%1.25M15.96%4.02M
Net other financing activities -129.28%-19.17M-19.74%-279K17.44%-142K-2,570.45%-5.88M-66.42%-12.87M-106.75%-8.36M-417.78%-233K-62.26%-172K56.95%-220K-128.74%-7.74M
Cash from discontinued financing activities
Financing cash flow 56.77%-60.6M39.14%-41.28M256.19%149.03M-152.47%-114.21M-179.28%-54.15M-132.10%-140.18M-162.66%-67.83M-205.30%-95.41M-88.75%-45.24M-86.81%68.3M
Net cash flow
Beginning cash position 36.18%239.99M-74.96%65.01M-38.92%173.94M-15.58%229.66M36.18%239.99M-6.74%176.24M89.93%259.58M127.35%284.8M149.01%272.03M-6.74%176.24M
Current changes in cash -324.88%-143.38M261.37%31.61M-331.99%-108.93M-536.34%-55.72M-110.79%-10.34M600.54%63.76M-149.50%-19.59M-321.12%-25.22M-20.31%12.77M220.15%95.79M
End cash Position -59.74%96.61M-59.74%96.61M-74.96%65.01M-38.92%173.94M-15.58%229.66M36.18%239.99M36.18%239.99M89.93%259.58M127.35%284.8M149.01%272.03M
Free cash flow -25.87%203.33M14.90%84.07M-112.50%-9.24M-32.65%67.13M123.20%61.37M123.71%274.29M11.91%73.17M73.37%73.95M149.23%99.67M208.15%27.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Lantheus
LNTH
+3.45%
Collegium Pharmaceutical
COLL
+2.59%
Constellation Brands
STZ
+1.73%
Halozyme Therapeutics
HALO
+0.75%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%

Unlock the Full List